Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6549666 | 0.98 | ALDH1A1 (0.37) | USP2KCNA5SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL8026943 | 0.80 | SMN1; SMN2 (0.37) | SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4359607 | 0.78 | USP2 (0.39) | USP2KCNA5SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL134990 | 0.77 | — | — | |
| SCHEMBL1777128 | 0.77 | — | — | |
| SCHEMBL23515492 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL11607003 | 0.75 | USP2 (0.41) | USP2KCNA5SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL29105480 | 0.75 | USP2 (0.41) | USP2KCNA5SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL9694114 | 0.75 | USP2 (0.46) | USP2KCNA5SMN1; SMN2PKMALDH1A1 | |
| Hydrochloric Acid SCHEMBL10975982 | 0.75 | ALDH1A1 (0.36) | USP2KCNA5SMN1; SMN2PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599207-A2 | TREATMENT OF EXCESSIVE OSTEOLYISIS WITH INDOLINONE COMPOUNDS | Sugen, Inc. (US) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004075775-A2 | TREATMENT OF EXCESSIVE OSTEOLYISIS WITH INDOLINONE COMPOUNDS | SUGEN, INC. (US) | 2004-09-10 | — | — | WO | disclosed |
| EP-1370554-A1 | 3-(4-AMIDOPYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 2003-12-17 | — | — | EP | disclosed |
| WO-2002066463-A1 | 3-(4-AMIDOPYRROL-2-YLMETHLIDENE)-2-INDOLINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 2002-08-29 | — | — | WO | disclosed |